Grace Colón Presents at the Oppenheimer Private Life Sciences Company Call Series
Grace Colón presented Transforming Cardiovascular Treatment with Pulmonary Delivery at the Oppenheimer Private Life Sciences Company Call Series on 8/18/2020 with Host: Leland Gershell, Oppenheimer & Co. Inc.
Grace presented how this is a major unmet market need Significant market (>30M patients globally; >$50B US healthcare costs). A differentiated approach with significant KOL, physician and patient support Clinical data supportive of target product profile; ready for Phase 3 in Q1 2021 and compelling value proposition for patients, payers and physicians.
This was the second virtual call series of summer 2020 highlighting 30 of the next generation life sciences private companies.